Douglas D. Watts

Array ( [id] => 2754092 [patent_doc_number] => 05071954 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-12-10 [patent_title] => 'Synthetic prothrombin peptides and antibodies directed against them' [patent_app_type] => 1 [patent_app_number] => 7/234121 [patent_app_country] => US [patent_app_date] => 1988-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4052 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/071/05071954.pdf [firstpage_image] =>[orig_patent_app_number] => 234121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2558084 [patent_doc_number] => 04942123 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-07-17 [patent_title] => 'ppRB.sup.110 -phosphoprotein the retinoblastoma susceptibility gene product' [patent_app_type] => 1 [patent_app_number] => 7/098612 [patent_app_country] => US [patent_app_date] => 1987-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 9995 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/942/04942123.pdf [firstpage_image] =>[orig_patent_app_number] => 098612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2555896 [patent_doc_number] => 04816436 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-03-28 [patent_title] => 'Anti-arthritic use of interleukin-1 proteins' [patent_app_type] => 1 [patent_app_number] => 6/925773 [patent_app_country] => US [patent_app_date] => 1986-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4684 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/816/04816436.pdf [firstpage_image] =>[orig_patent_app_number] => 925773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3264973 [patent_doc_number] => 04116950 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1978-09-26 [patent_title] => 'Analogs of human .beta.-endorphin' [patent_app_type] => 1 [patent_app_number] => 5/869555 [patent_app_country] => US [patent_app_date] => 1978-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2651 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/116/04116950.pdf [firstpage_image] =>[orig_patent_app_number] => 869555 [rel_patent_id] =>[rel_patent_doc_number] =>)